Business Description
Akeso Inc
ISIN : KYG0146B1032
Share Class Description:
AKESF: Ordinary SharesCompare
Compare
Traded in other countries / regions
09926.Hong KongAKESF.USA4RY.Germany IPO Date
2021-09-03Description
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.64 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 1.38 | |||||
| Interest Coverage | 24.91 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.56 | |||||
| Beneish M-Score | 0.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 8.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -23.81 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.04 | |||||
| 9-Day RSI | 2.73 | |||||
| 14-Day RSI | 13.58 | |||||
| 6-1 Month Momentum % | 26.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.71 | |||||
| Quick Ratio | 4.39 | |||||
| Cash Ratio | 4.06 | |||||
| Days Inventory | 939.18 | |||||
| Days Sales Outstanding | 22.06 | |||||
| Days Payable | 858.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | -2.8 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.06 | |||||
| Operating Margin % | 47.87 | |||||
| Net Margin % | 44.81 | |||||
| FCF Margin % | 35.01 | |||||
| ROE % | 48.46 | |||||
| ROA % | 25.56 | |||||
| ROIC % | 62.1 | |||||
| ROC (Joel Greenblatt) % | 76.5 | |||||
| ROCE % | 30.03 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.7 | |||||
| PE Ratio without NRI | 19.19 | |||||
| Price-to-Owner-Earnings | 19.5 | |||||
| PS Ratio | 8.37 | |||||
| PB Ratio | 8.11 | |||||
| Price-to-Tangible-Book | 8.71 | |||||
| Price-to-Free-Cash-Flow | 23.86 | |||||
| Price-to-Operating-Cash-Flow | 15.36 | |||||
| EV-to-EBIT | 18.28 | |||||
| EV-to-EBITDA | 17.08 | |||||
| EV-to-Revenue | 8.2 | |||||
| EV-to-Forward-Revenue | 13.82 | |||||
| EV-to-FCF | 23.36 | |||||
| Price-to-Graham-Number | 2.72 | |||||
| Price-to-Net-Current-Asset-Value | 32.11 | |||||
| Price-to-Net-Cash | 87.14 | |||||
| Earnings Yield (Greenblatt) % | 5.47 | |||||
| FCF Yield % | 4.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AKESF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akeso Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 632.386 | ||
| EPS (TTM) ($) | 0.337 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 13.58 | ||
| 14-Day ATR ($) | 0.016514 | ||
| 20-Day SMA ($) | 6.276 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 5 - 6.45 | ||
| Shares Outstanding (Mil) | 865.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akeso Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akeso Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Akeso Inc Frequently Asked Questions
What is Akeso Inc(AKESF)'s stock price today?
The current price of AKESF is $6.10. The 52 week high of AKESF is $6.45 and 52 week low is $5.00.
When is next earnings date of Akeso Inc(AKESF)?
The next earnings date of Akeso Inc(AKESF) is 2024-09-26 Est..
Does Akeso Inc(AKESF) pay dividends? If so, how much?
Akeso Inc(AKESF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers